IART 250117 20.00C (IART250117C20000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

IART250117C20000

Watchlist

1.05
0.000.00%

15min DelayClose Jan 7 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Integra LifeSciences Reaffirms Q4 Revenue View $441M-$451M, Consensus $445.15M
TipRanksJan 7 06:51 ET
Sell Rating Issued for Integra Lifesciences Amidst FDA Warning and Leadership Changes
TipRanksJan 7 05:36 ET · Ratings
BofA Securities Maintains Integra Lifesciences(IART.US) With Sell Rating, Cuts Target Price to $21
Moomoo NewsJan 7 05:33 ET · Ratings
Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating
Moomoo NewsJan 6 19:32 ET · Ratings
Wells Fargo Sticks to Its Hold Rating for Integra Lifesciences (IART)
TipRanksJan 6 19:06 ET · Ratings
Citi Says Avoid These Stocks in '25; SA Quant Ratings Says Not so Fast
Seeking AlphaJan 6 12:21 ET

Comments

Money Mover

Jul 1, 2024 10:35

Going to miss guidance/earnings

$Integra Lifesciences (IART.US)$ its a buy at $24

Money Mover

Jun 27, 2024 14:20

$Integra Lifesciences (IART.US)$ Integra LifeSciences Price Target Cut to $25.00/Share From $45.00 by Wells Fargo

Moomoo AI

Feb 11, 2024 08:35

EPS growth doesn't align with share price, indicating it may not reflect business performance or growth expectations may have been high. Integra LifeSciences Holdings' performance led to a 3% annual loss for shareholders over five years. Investors should note 3 warning signs.

While Shareholders of Integra LifeSciences Holdings (NASDAQ:IART) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Moomoo AI

Jan 29, 2024 04:30

Insider transactions suggest a positive outlook for Integra LifeSciences Holdings, with insiders net buying the stock. The level of insider ownership indicates a reasonable degree of alignment with shareholder interests.

Several Insiders Invested In Integra LifeSciences Holdings Flagging Positive News

Moomoo AI

Jan 15, 2024 05:36

Integra LifeSciences Holdings trades at a low price, suggesting a buying opportunity. Higher cash flow is expected, potentially boosting share valuation. The positive outlook seems not fully factored into the share price, indicating it's not too late to buy IART.

At US$42.94, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?